Prevalence of Class A and AmpC β-Lctamases in clinical Escherichia coli isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan

Japanese Journal of Infectious Diseases

Volumn 64, Issue 3, 2011, Pages 249-252

  Hussain, Masroor ^a,b   Hasan, Fariha ^b   Shah, Aamir Ali ^b   Hameed, Abdul ^b   Jung, Myunghwan ^a   Rayamajhi, Nabin ^a   Cha, Seung Bin ^a   Yoo, Han Sang ^a  

^a Seoul National University   (South Korea)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE AMPC; BETA LACTAMASE BIL 1; BETA LACTAMASE CIT; BETA LACTAMASE CMY 1; BETA LACTAMASE CMY 2; BETA LACTAMASE CMY 3; BETA LACTAMASE CMY 4; BETA LACTAMASE CMY 5; BETA LACTAMASE CMY 6; BETA LACTAMASE CMY 7; BETA LACTAMASE CTX M; BETA LACTAMASE LAT 1; BETA LACTAMASE LAT 2; BETA LACTAMASE LAT 3; BETA LACTAMASE LAT 4; BETA LACTAMASE MOX 1; BETA LACTAMASE MOX 2; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BETA LACTAMASE AMPC GENE; BIL 1 GENE; CIT GENE; CMY 1 GENE; CMY 10 GENE; CMY 11 GENE; CMY 2 GENE; CMY 3 GENE; CMY 4 GENE; CMY 5 GENE; CMY 6 GENE; CMY 7 GENE; CMY 8 GENE; CMY 9 GENE; CONTROLLED STUDY; CTX M GENE; DISK DIFFUSION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE GENE; LAT 1 GENE; LAT 2 GENE; LAT 3 GENE; LAT 4 GENE; MOX 1 GENE; MOX 2 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PAKISTAN; POLYMERASE CHAIN REACTION; SHV GENE; TEM GENE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PAKISTAN; PLASMIDS; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 79958024008     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hsieh, C.J., Shen, Y.H. and Hwang, K.P. (2010): Clinical implications, risk factors and mortality following community-onset bacteremia caused by extended-spectrum β-lactamase (ESBL) and non-ESBL producing Escherichia coli. J. Microbiol. Immunol. Infect., 43, 240-248.
2. Peterson, L.R. (2008): Antibiotic policy and prescribing strategies for therapy of extended-spectrum β-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam. Clin. Microbiol. Infect., 14, 181-184.
3. Tzouvelekis, L.S., Tzelepi, E., Tassios, P.T., et al. (2000): CTXM- type β-lactamases: an emerging group of extended spectrum enzymes. Int. J. Antimicrob. Agents, 14, 137-142.
4. Bonnet R. (2004): Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother., 48, 1-14.
5. Livermore, D.M., Canton, R., Gniadkowski, M., et al. (2007): CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother., 59, 165-174.
6. Pitout, J.D. and Laupland, K.B. (2008): Extended-spectrum β-lactamase- producing Enterobacteriaceae: an emerging publichealth concern. Lancet Infect. Dis., 8, 159-166.
7. Philippon, A., Arlet, G. and Jacoby, G. (2002): Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother., 46, 1-11.
8. Sundin, D.R. (2009): Hidden beta-lactamases in the Enterobacteriaceae- dropping the extra disks for detection, Part II. Clin. Microbiol. Newsl., 31, 47-52.
9. Nelson, E.C. and Elisha, B.G. (1999): Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. Antimicrob. Agents Chemother., 43, 957-959.
10. Mammeri, H., Nazic, H., Naas, T., et al. (2004): AmpC β-lactamase in an Escherichia coli clinical isolate confers resistance to expanded spectrum cephalosporins. Antimicrob. Agents Chemother., 48, 4050-4053.
11. Kim, J.Y., Sohn, J.W., Park, D.W., et al. (2008): Control of extended- spectrum beta-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use. J. Antimicrob. Chemother., 62, 416-421.
12. Bush, K. and Jacoby, G.A. (2009): Updated functional classification of beta-lactamases. Antimicob. Agents Chemother., 54, 969-976.
13. Clinical and Laboratory Standards Institute (2009): Performance standards for antimicrobial susceptibility testing; 19th informational supplement M100-S19. Clinical and Laboratory Standards Institute, Wayne, Pa., USA.
14. Rayamajhi, N., Cha, S.B., Kang, M.L., et al. (2009): Inter- and Intraspecies plasmid-mediated transfer of florfenicol resistance in Enterobacteriaceae isolates from swine. App. Environ. Microbiol., 75, 5700-5703.
15. Perez-Perez, F.J. and Hanson, N.D. (2002): Detection of plasmid- mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol., 40, 2153-2162.
16. Oteo, J., Navarro, C., Cercenado, E., et al. (2006): Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J. Clin. Microbiol., 44, 2359-2366.
17. Dias, R.C.S., Borges-Neto, A.A., Ferraiuoli, G.I.D., et al. (2008): Prevalence of AmpC and other β-lactamases in enterobacteria at a large urban university hospital in Brazil. Diagn. Microbiol. Infect. Dis., 60, 79-87.
18. Mendonca, N., Ferreira, E., Louro, D., et al. (2009): Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal. Int. J. Antimicrob. Agents, 34, 29-37.
19. Pitout, J.D., Hossain, A. and Hanson, N.D. (2004): Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp. J. Clin. Microbiol., 42, 5715-5721.
20. Jabeen, K., Zafar, A., Irfan, S., et al. (2010): Increase in isolation of extended spectrum beta lactamase producing multidrug resistant non typhoidal Salmonellae in Pakistan. BMC Infect. Dis., 10, 101-106.
21. Shahid, M., Malik, A., Akram, M., et al. (2008): Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmidmediated cefoxitin resistance. Int. J. Infect. Dis., 12, 256-264.
22. Kiffer, C.R., Kuti, J.L., Eagye, K.J., et al. (2006): Pharmacodynamic profiling of imipenem, meropenem and ertapenem against clinical isolates of extended-spectrum β-lactamaseproducing Escherichia coli and Klebsiella spp. from Brazil. Int. J. Antimicrob. Agents, 28, 340-344.
23. Kim, J., Lim, Y.M., Jeong, Y.S., et al. (2005): Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extendedspectrum beta-lactamases in Enterobacteriaceae clinical isolates in Korea. Antimicrob. Agents Chemother., 49, 1572-1575.
24. Urban, C., Mariano, N., Bradford, P.A., et al. (2010): Identification of CTX-M β-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities. Diagn. Microbiol. Infect. Dis., 66, 402-406.
25. Castanheira, M., Mendes, R.E., Rhomberg, P.R., et al. (2008): Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. medical centers: molecular evaluation from the MYSTIC Program (2007). Microb. Drug Resist., 14, 211-216.
26. Romero, E.D., Padilla, T.P., Hernaá ndez, A.H., et al. (2007): Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum β-lactamases. Diagn. Microbiol. Infect. Dis., 59, 433-437.
27. Bogaerts, P., Rodriguez-Villalobos, H., Bauraing, C., et al. (2010): Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered at two Belgian hospitals. Pathol. Biol. (Paris), 58, 78-83.
28. Woodford, N., Reddy, S., Fagan, E.J., et al. (2007): Wide geographic spread of diverse acquired AmpC β-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J. Antimicrob. Chemother., 59, 102-105.
29. Jacoby, GA. (2009): AmpC β-lactamases. Clin. Microbiol. Rev., 22, 161-182.
30. Qi, C., Pilla, V., Yu, J.H., et al. (2010): Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum β-lactamases in outpatient urinary E. coli between 2003 and 2008. Diagn. Microbiol. Infect. Dis., 67, 87-91.
31. Xiong, Z., Zhu, D., Wang, F., et al. (2002): Investigation of extended- spectrum β-lactamase in K. pneumoniae and E. coli from China. Diagn. Microbiol. Infect. Dis., 44, 195-200.
32. Vercauteren, E., Descheemaeker, P., Ieven, M., et al. (1997): Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J. Clin. Microbiol., 35, 2191-2197.
33. De Gheldre, Y., Avesani, V., Berhin, C., et al. (2003): Evaluation of Oxoid combination discs for detection of extended-spectrum β-lactamases. J. Antimicrob. Chemother., 52, 591-597.